MIRA INFORM REPORT

Report Date :

24.05.2011

IDENTIFICATION DETAILS

Name :	BREEZE PHARMA (PRIVATE.) LIMITED

Registered Office :	125-126-127A, Industrial Triangle, Kahuta Road, Islamabad

Country :	Pakistan

Year of Establishment :	2008

Com. Reg. No.:	0067279

Legal Form :	Private Limited Company

Line of Business :	Manufacture & Marketing of Veterinary Pharmaceutical Products

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small

Status :	Moderate
Payment Behaviour :	Unknown
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2011

Country Name

Previous Rating

(31.12.2010)

Current Rating

(31.03.2011)

Pakistan

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Bottom of Form

Business Name

BREEZE PHARMA (PRIVATE.) LIMITED

Full Address

Registered Address

125-126-127A, Industrial Triangle, Kahuta Road, Islamabad, Pakistan

Tel #	92 (51) 4491969, 4492635
Fax #	92 (51) 4492634
Email	zeejah_fazli@hotmail.com

Short Description Of Business

a.	Nature of Business	Manufacture & Marketing of Veterinary Pharmaceutical Products
b.	Year Established	2008
c.	Registration #	0067279

Branches

Address	Plot # 81-A, Street No 6, I-10/3, Islamabad, Pakistan
Tel #	92 (51) 4441081, 4444009
Fax #	92 (51) 4444009

Auditors

Shahzad Qazi & Co.

(Chartered Accountants)

Legal Status

Subject Company was established as a Private Limited Company in 2008

Authorized Capital	Rs. 120,000,000/- divided into 1,200,000 shares of Rs. 100/- each
Issued & Paid up Capital	Rs. 1,000,000/- divided into 10,000 shares of Rs. 100/- each

Details of Directors

Names

Nationality

Address

Occupation

Designation

Mr. Tariq Masood

Mr. Irfan Mehmood Qazi

Mr. Zeejah Fazli

Mr. Yahya Mehmood

Pakistani

125-126-127A, Industrial Triangle, Kahuta Road, Islamabad

Business

Chief Executive

Director

Shareholders

Names of Shareholders

No. of Shares

Mr. Muhammad Amjad

Mrs. Tehmina Amjad

Mr. Zohaib Amjad

Mr. Jahanzaib Amjad

Mr. Tariq Masud

Mr. Jawad Tariq

Mr. Tariq Mehmood

Mr. Muhammad Dawood

Mr. Sheikh Khalid Mehmood

Mr. Irfan Mehmood

2,100

1,000

500

1,000

900

Associates

A. Subsidiary

None

B. Associated Companies

(1) Eterna International (Pvt.) Ltd, Pakistan

Products

Manufacture & Marketing of Veterinary Pharmaceutical Products by its brand names of TYLO-PRO 20, GENTA-PRO, GENTRAX 20, COLIGENT, CEFPRO, AQUA PRO, GENCOTYL, TYLOGENT, TYCOLIMET, SPECTRAL, HIT-CRD, CIPROSET 20, TYLOSTREP

Number of Employees

Annual Production Volume

The capacity and production of the company’s plant is indeterminable as it is multi-product and involves varying processes of manufacture

Annual Sales Volume

Year	In Pak Rupees
2009 - 2010	40,000,000/- (Estimated)

Importing Countries

Import of Pharmaceutical Raw Materials from Europe, India & China

Distributors

Subject authorized distributors currently exist in all major cities of Pakistan

Bankers

(1) Habib Bank Limited, Pakistan.

(2) MCB Bank Limited, Pakistan.

(3) Askari Bank Limited, Pakistan.

(4) Bank Al-Habib Limited, Pakistan.

Memberships

· Rawalpindi Chamber of Commerce & Industry.

Foreign Exchange Rates

Currency	Unit	Pakistani Rupee
US Dollar	1	Rs. 86.00
UK Pound	1	Rs. 139.30
Euro	1	Rs. 121.20

Comments

Subject Company was incorporated in 2008 and is engaged in manufacture & marketing of Pharmaceutical Products. Overall reputation is normal. Trade relations are reported as fair. Subject can be considered for normal business dealings at usual trade terms and conditions.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.45.28
UK Pound	1	Rs.73.30
Euro	1	Rs.63.61

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
----	NB	New Business	----

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.